Skip to main content
Toggle menu
Home
genes
genes
The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2 million per person
Sat, 12/09/2023 - 15:12
Tech Insider
The FDA approved the first gene therapy for sickle cell anemia.
Meletios Verras/ iStock
health
,
News
,
health
,
sickle-cell-disease
,
anemia
,
nobel-prize
,
gene-editing
Subscribe to genes
sfy39587stp18
The FDA approved the first gene therapy for sickle cell anemia.